Toxicity associated with gadolinium-based contrast-enhanced examinations (May 2021).

May 8

Written By Bridget Belo

Download Article

Article link: https://www.aimspress.com/article/doi/10.3934/biophy.2021015

Journal: AIMS Biophysics

Author and Affiliation: Silvia Maria Lattanzio , Department of Biomedical Sciences, University of Padua, Padua, Italy.

depositiontoxicitycumulative metal toxicityrate of administrationdetoxificationpharmaco-kineticadverse drug reactiongadolinium-associated systemic fibrosisbrainhairboneosteoporosiscortical bone tissuedelayed mobilization of gadolinium from bone storesmetal depositionmass spectrometryhair analysisdentate nucleusgadolinium intoxicationfingernail analysisSemelkaGadolinium Storage Conditionmembrane potentialsenzyme inhibitionnonspecific protein conformational effectscerebrospinal fluidintact complexes internalized by leukocytes and erythrocytesspeciationquantitative analysisstudies designed not to identify long-term health effectschronic toxicitymultiple-dose GBCAperinatal exposureperinatal impaired brain developmentperinatal GBCA stillbirthGBCA premature loss of ovarian functiondechelationtransmetallationinflammation facilitates gadolinium retentionglymphatic systemfactors that might play a role in retention/toxicitycumulative doseoff-label userate of GBCA administrationrecommended injection rate is 2-3 ml/s (0.5 mmol/ml)Electromagnetic fieldEMFprevious metal burdenFDA recommended minimizing "repeat GBCA imaging studies when possible"FDA recommended minimizing "particularly closely spaced MRI studies"lanthanum impuritiesgender differenceswomenX-ray absorptionanthropogenic gadolinium

Bridget Belo

Gadolinium Retention in Human Brain, Bone, and Skin (June 2021).

Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis (Feb 2021).

Submit any resources that should be included on the site.

Explore Gadolinium 64

This site is also accessible via contrastdie.com

Fair Use Disclaimer
This website features copyrighted material used in accordance with the principles of fair use as outlined in Section 107 of the U.S. Copyright Act. The material is provided to inform, educate, and encourage public discussion on important issues, including health, education, and science. All content is shared with the intent of advancing understanding and fostering meaningful dialogue. This use is non-commercial and aligns with fair use standards for purposes such as research, education, and commentary. If you believe any content on this site infringes on your copyright, please contact us at Contact Us and we will review your concerns promptly.